Why Genetic Predisposition Insights May Inform Your Cost-Benefit Analysis Before committing to a specific GLP-1 provider or medication, understanding your genetic predispositions in peptide pathways may help provide context for personalization discussions with a qualified healthcare provider
Kunal Singals observation captures the reality: demand isnt disappearing, its shifting
Pregnancy is contraindicated
2,3 Demand has grown rapidly, raising questions about real-world uptake, prescribing patterns across clinical indications, and whether population-level BMI distributions are beginning to shift in response
For patients on GLP-1 medications, AI can flag elevated risks for specific complications, prompting clinicians to adjust therapy or order targeted tests before symptoms appear
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment